Cat.#: ACPP-1278
| Despition | EAAT1 Blocking Peptide for Immunocompetition, Immunodepletion |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1013 | Recombinant Human GPCR GPRC5B Protein (Fc Tag) (AC1013) | 50 µg | inquiry |
| ACPP-1393 | Human ALDH3A1 Protein (AC1393) | 2 µg | inquiry |
| ACPP-1472 | Human PAX8 Protein (AC1472) | 2 µg | inquiry |
| ACPP-1678 | Human SDCBP Protein (AC1678) | 5 µg | inquiry |
| ACPP-1764 | Human ANTXR2 Protein (AC1764) | 2 µg | inquiry |
| ACPP-1621 | Human LZIC Protein (AC1621) | 5 µg | inquiry |
| ACPP-1530 | Mouse METRN Protein (AC1530) | 1 µg | inquiry |
| ACPP-1307 | NPY2R Blocking Peptide (AC1307) | 250 µg | inquiry |
| ACPP-1774 | Human CRKL Protein (AC1774) | 5 µg | inquiry |
| ACPP-1213 | CACNB2 Blocking Peptide (AC1213) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.